These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. Feldman C. J Lab Clin Med; 2004 May 01; 143(5):269-83. PubMed ID: 15122171 [Abstract] [Full Text] [Related]
12. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project. Bratzler DW, Ma A, Nsa W. Clin Infect Dis; 2008 Dec 01; 47 Suppl 3():S193-201. PubMed ID: 18986289 [Abstract] [Full Text] [Related]
13. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections. Furuno JP, Metlay JP, Harnett JP, Wilson J, Langenberg P, McGregor JC, Zhu J, Perencevich EN. Pharmacoepidemiol Drug Saf; 2006 Jan 01; 15(1):1-9. PubMed ID: 16136615 [Abstract] [Full Text] [Related]
14. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Anon JB. Paediatr Drugs; 2003 Jan 01; 5 Suppl 1():25-33. PubMed ID: 14632103 [Abstract] [Full Text] [Related]
15. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN, Micek ST, Reichley RM, Ritchie DJ. Clin Ther; 2009 Feb 01; 31(2):299-310. PubMed ID: 19302902 [Abstract] [Full Text] [Related]